IU Health Arnett Cancer Center

Lafayette, Indiana 47904

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Cachexia, Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, Fatigue, Loss of Appetite, Malignant Neoplasm of Breast, Multiple Myeloma, Non-small Cell Lung Cancer, Pancreatic Cancer, Prostate Cancer, Small Cell Lung Cancer

Studies at this site

• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
• Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 — Completed
• Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma — Stopped early
• Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer — Completed
• Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC — Completed
• Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) — Stopped early
• Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer — Completed